{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:13:27Z","timestamp":1789503207561,"version":"build-2803163510"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T00:00:00Z","timestamp":1326844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030341","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T16:44:15Z","timestamp":1326905055000},"page":"e30341","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":121,"title":["CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder"],"prefix":"10.1371","volume":"7","author":[{"given":"Pericles","family":"Calias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Papisov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Savioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasily","family":"Belov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lotterhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Alessandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Heartlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier.","volume":"37","author":"NJ Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuroscience.2004.07.003","article-title":"Molecular mechanisms of cerebrospinal fluid production.","volume":"129","author":"PD Brown","year":"2004","journal-title":"Neuroscience"},{"key":"ref3","first-page":"1288","article-title":"Ventricular organization of the cerebrospinal fluid: blood-brain barrier, brain edema, and hydrocephalus","author":"J Laterra","year":"2000"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: the future of brain drug development.","volume":"3","author":"WM Pardridge","year":"2003","journal-title":"Mol Interv"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10611860903353362","article-title":"Genetic engineering of IgG-glucuronidase fusion proteins.","volume":"18","author":"RJ Boado","year":"2010","journal-title":"J. Drug Target"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbiotec.2009.08.019","article-title":"AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys.","volume":"144","author":"RJ Boado","year":"2009","journal-title":"J Biotechnol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/bit.22135","article-title":"Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse.","volume":"102","author":"RJ Boado","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/mp900235k","article-title":"Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor.","volume":"7","author":"RJ Boado","year":"2010","journal-title":"Mol Pharm"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jgm.255","article-title":"Receptor-mediated delivery of an antisense gene to human brain cancer cells.","volume":"4","author":"Y Zhang","year":"2002","journal-title":"J Gene Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1007592720793","article-title":"Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.","volume":"17","author":"MJ Coloma","year":"2000","journal-title":"Pharm Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/17425240902939143","article-title":"The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.","volume":"6","author":"E Barbu","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2146\/ajhp060204","article-title":"Intrathecal drug therapy for long-term pain management.","volume":"64","author":"VL Ghafoor","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nurt.2007.10.070","article-title":"Intrathecal pumps.","volume":"5","author":"S Belverud","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/17425240903540205","article-title":"Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.","volume":"7","author":"RG Soderquist","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/foc.2006.21.2.6","article-title":"Intrathecal baclofen in the treatment of adult spasticity.","volume":"21","author":"JC Hsieh","year":"2006","journal-title":"Neurosurg Focus"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000070870","article-title":"Complications of intrathecal baclofen pumps in children.","volume":"39","author":"JL Gooch","year":"2003","journal-title":"Pediatr Neurosurg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.","volume":"60","author":"JG Nutt","year":"2003","journal-title":"Neurology"},{"issue":"Suppl","key":"ref18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-211-33081-4_16","article-title":"GDNF delivery for Parkinson's disease.","volume":"97","author":"NK Patel","year":"2007","journal-title":"Acta Neurochir"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005178","article-title":"Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer.","volume":"CD005178","author":"JC Ballantyne","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1040-8428(00)00115-3","article-title":"Intrathecal chemotherapy. Crit.","volume":"37","author":"JZ Kerr","year":"2001","journal-title":"Rev Oncol Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM196212202672502","article-title":"Subarachnoid distribution of drugs after lumbar injection.","volume":"267","author":"RE Rieselbach","year":"1962","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0306-4522(96)00281-3","article-title":"Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat.","volume":"75","author":"JF Ghersi-Egea","year":"1996","journal-title":"Neuroscience"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0306-4522(99)00417-0","article-title":"Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat.","volume":"95","author":"MG Proescholdt","year":"2000","journal-title":"Neuroscience"},{"key":"ref24","first-page":"431","article-title":"Rapid solute transport throughout the brain via paravascular fluid pathways.","volume":"52","author":"ML Rennels","year":"1990","journal-title":"Adv Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(85)91383-6","article-title":"Evidence for a \u2018paravascular\u2019 fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space.","volume":"326","author":"ML Rennels","year":"1985","journal-title":"Brain Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders.","volume":"281","author":"PJ Meikle","year":"1999","journal-title":"J Am Med Assoc"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).","volume":"121","author":"R Martin","year":"2008","journal-title":"Pediatrics"},{"key":"ref28","year":"2010"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2174\/138161208784705504","article-title":"Lysosomal storage diseases and the blood-brain barrier.","volume":"14","author":"DJ Begley","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00221-007-1067-0","article-title":"Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.","volume":"Res182","author":"SY Tsai","year":"2007","journal-title":"Exp Brain"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.","volume":"83","author":"E Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.1988.tb31809.x","article-title":"Drug \u201cdiffusion\u201d within the brain.","volume":"531","author":"J Fenstermacher","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.26.1.1","article-title":"Spinal descent of cerebrospinal fluid in man.","volume":"26","author":"GD Chiro","year":"1976","journal-title":"Neurology"},{"key":"ref34","first-page":"83","article-title":"Fluid compartments of the central nervous system.","author":"MB Segal","year":"2005"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/0192623311409595","article-title":"Safety evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys.","volume":"39","author":"BR Felice","year":"2011","journal-title":"Toxicol Pathol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).","volume":"30","author":"AR Garcia","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543784.11.5.675","article-title":"Enzyme replacement therapy for the mucopolysaccharide storage disorders.","volume":"11","author":"ED Kakkis","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"ref38","first-page":"S118","article-title":"Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases. Int J Clin Pharmacol.","volume":"1)","author":"KM Hemsley","year":"2009","journal-title":"Ther 47 (Suppl"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-007-0325-3","article-title":"Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue.","volume":"115","author":"K Hamano","year":"2008","journal-title":"Acta Neuropathol"},{"key":"ref40","first-page":"1029","article-title":"Evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys Am J Neuroradiol","volume":"28","author":"L Vedolin","year":"2007"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00234-004-1215-1","article-title":"Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation.","volume":"46","author":"MG Matheus","year":"2004","journal-title":"Neuroradiology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years.","volume":"154","author":"N Guffon","year":"2009","journal-title":"J Pediatr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuropharm.2009.12.015","article-title":"Stem cell transplantation for neurometabolic and neurodegenerative diseases.","volume":"58","author":"LS Shihabuddin","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.22-15-06437.2002","article-title":"Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream.","volume":"22","author":"MA Passini","year":"2002","journal-title":"J Neurosci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1523\/JNEUROSCI.2185-07.2007","article-title":"A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease.","volume":"27","author":"CN Cearley","year":"2007","journal-title":"J Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ymthe.2005.06.438","article-title":"Axons mediate the distribution of arylsulfatase A within the mouse hippocampus upon gene delivery.","volume":"12","author":"T Luca","year":"2005","journal-title":"Mol Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/85454","article-title":"In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice.","volume":"7","author":"A Consiglio","year":"2001","journal-title":"Nat Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/hmg\/ddq099","article-title":"Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models.","volume":"19","author":"A Lattanzi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","article-title":"Viral vectors for gene delivery to the nervous system.","volume":"4","author":"BL Davidson","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/sj.gt.3302087","article-title":"Adeno-associated virus vector-mediated transduction in the cat brain.","volume":"10","author":"CH Vite","year":"2003","journal-title":"Gene Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00018-004-4206-9","article-title":"Integration target site selection for retroviruses and transposable elements.","volume":"61","author":"X Wu","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood-2002-07-2238","article-title":"Lentiviral vector transduction of NOD\/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.","volume":"101","author":"NB Woods","year":"2003","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1371\/journal.pbio.0020423","article-title":"Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.","volume":"2","author":"P Hematti","year":"2004","journal-title":"PLoS Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng1179","article-title":"AAV serotype 2 vectors preferentially integrate into active genes in mice.","volume":"34","author":"H Nakai","year":"2003","journal-title":"Nat Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neurobiolaging.2005.03.005","article-title":"Cellular distribution of insulin-like growth factor-II\/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.","volume":"27","author":"S Kar","year":"2006","journal-title":"Neurobiol Aging"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0953-816x.2001.01864.x","article-title":"Insulin-like growth factor-II\/Mannose-6-phosphate receptor in the spinal cord and dorsal root ganglia of the adult rat.","volume":"15","author":"C Hawkes","year":"2002","journal-title":"Eur J Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ymgme.2005.11.017","article-title":"Alpha-L-Iduronidase transport in neurites.","volume":"87","author":"F Chen","year":"2006","journal-title":"Mol Genet Metab"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter Syndrome).","volume":"8","author":"J Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis.","volume":"2","author":"AM Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1109\/42.363108","article-title":"Accelerated image reconstruction using ordered subsets of projection data.","volume":"13","author":"HM Hudson","year":"1994","journal-title":"IEEE Trans Med Imaging"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1088\/0031-9155\/43\/4\/027","article-title":"High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner.","volume":"43","author":"J Qi","year":"1998","journal-title":"Phys Med Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1109\/42.563660","article-title":"Exact and approximate rebinning algorithms for 3-D PET data.","volume":"16","author":"M Defrise","year":"1997","journal-title":"IEEE Trans Med Imaging"},{"key":"ref63","first-page":"1751","article-title":"PET imaging of protein pharmacokinetics in the CSF of rats and monkeys with I-124.","volume":"2)","author":"M Papisov","year":"2010","journal-title":"J Nucl Med 51 (Suppl"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).","volume":"24","author":"YV Voznyi","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).","volume":"30","author":"AR Garcia","year":"2007","journal-title":"J Inherit Metab Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T13:12:26Z","timestamp":1561209146000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030341"}},"subtitle":[],"editor":[{"given":"Maria A.","family":"Deli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,18]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030341","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,18]]}}}